Menu Menu

CTKB    Cytek Biosciences Inc    1831915    
Income Statement
Revenue 200,453,000
Net Income -6,020,000
Profit Margin -3%

Balance Sheet
Current Assets 396,446,000
Assets 499,500,000
Current Liabilities 67,663,000
Liabilities 103,763,000
Equity 395,737,000
Shares Out 131,506,000

Cash Flow Statement
Operating Cash Flow 25,379,000
Investing Cash Flow -82,974,000

Market Analysis
Market Cap 700,922,705
Price 4.28
BVPS 3.01
PB 1.40
EPS -0.13
PS 0.87
FCF -57,595,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/28
Apr May Jun
5/08 -0.05
Jul Aug Sep
8/06 -0.08
Oct Nov Dec
11/05

Find a discrepancy? The most accurate way to find company fundamental data is to view CTKB documents filed with the SEC.


CTKB Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: